Taken together, our data indicate that pterostilbene inhibited lung metastasis and/or suppression of lung cancer stem cells via the downregulation of NF-κB, p65 signaling, and cancer stemness activation, acting through M2-TAMs (Figure 5D). The gene discussed is NFKB1; the disease is lung cancer.